The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Praxilene 100 mg Capsules



Merck Serono (Ireland) LimitedPA2286/003/001

Main Information

Trade NamePraxilene 100 mg Capsules
Active SubstancesNAFTIDROFURYL OXALATE
Dosage FormCapsule, hard
Licence HolderMerck Serono (Ireland) Limited
Licence NumberPA2286/003/001

Group Information

ATC CodeC04AX Other peripheral vasodilators
C04AX21 naftidrofuryl

Status

License statusAuthorised
Licence Issued01/04/1980
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceNone
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back